Risk-Oriented Therapy for Myeloid Leukemia of Down Syndrome: A Nationwide Prospective Study By the Japanese Pediatric Leukemia / Lymphoma Study Group (JPLSG)
Takashi Taga(Erasmus MC), Souichi Adachi(Kyoto University), Keizo Horibe(National Hospital Organization), Daisuke Tomizawa(National Center For Child Health and Development), Tatsutoshi Nakahata(Kyoto University), Akira Shimada(Tohoku University), Akio Tawa(Erasmus MC), Hiroaki Goto(Yokohama City University), Akitoshi Kinoshita(St. Marianna University School of Medicine), Katsuyoshi Koh(Saitama Children's Medical Center), Etsuro Ito(Okayama University), Tsutomu Toki(Hirosaki University), Tomohiko Taki(Kyorin University), Hiroshi Moritake(University of Miyazaki), Tomoyuki Watanabe(Aichi Gakuin University), Akiko Saito(Nagoya University Hospital), Hiroyuki Takahashi(Children's Cancer Association of Japan), Hideki Nakayama(National Hospital Organization Kyushu Cancer Center), Kazuko Kudo(Shizuoka Children's Hospital), Shotaro Iwamoto(Mie University), Kiminori Terui(Hirosaki University)
Cited by 1
Related Papers
Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
|Immunity|2009|2.3k
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
|Journal of Clinical Oncology|2015|1k
Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel
|Blood|2012|575
NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity
|Nature Genetics|2016|473
Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia
|Journal of Clinical Oncology|2015|383